Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-24 @ 11:55 PM
NCT ID:
NCT03947151
Eligibility Criteria:
Inclusion Criteria:
* Patients with invasive ductal carcinoma breast cancer, whatever the hormonal receptor expression profile
* Age : 18 - 40 years
* Presence of 2 ovaries
* Antral follicular count between 12 and 30 on both ovaries and/or recent measurement of serum anti-Müllerian hormone between 1.5 and 4 ng / mL (between Day-25 and Day0)
* Indication of chemotherapy
* Indication of preservation of fertility according to an oocyte vitrification technique after controlled ovarian stimulation (COS)
* Patient in the early follicular phase of the cycle at the start of the controlled ovarian stimulation (COS) (absence of follicle\> 10 mm in ultrasound and estradiolemia \<50 pg / mL)
* Oncology team agreement for the controlled ovarian stimulation (COS)
* Social insured patient
* Patient who gave her consent to participate by signing the consent of the study
Exclusion Criteria:
* Patient in late follicular phase or luteal phase
* Known hypersensitivity to one of the constituents of Firmagon®
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
40 Years
Study:
NCT03947151
Study Brief:
Protocol Section:
NCT03947151